Tirzepatide noninferior to dulaglutide with respect to composite of death from cardiovascular causes, myocardial infarction, ...

It may be safe to omit stenting in some STEMI patients who have adequate flow restored and minimal residual stenosis, according to a look back at data from the DANAMI3-DEFER trial. Yet researchers ...

PHOENIX -- Withdrawal of care was a common cause of death for ST-elevation myocardial infarction (STEMI) patients, with only rare use of palliative care, a single-center study showed. Overall, 24.6% ...

The Society of Cardiovascular Angiography and Interventions has published an expert consensus statement on the management of patients with ST-elevation myocardial infarction. Experts agree reperfusion ...

Please provide your email address to receive an email when new articles are posted on . Risk for death was lower with the pump vs. standard care only, but incidence of adverse events was elevated. The ...

Myocardial infarction (MI) causes millions of deaths worldwide. Though there have been advances in the survival rates following ST-elevation MI (STEMI), survivors often develop heart failure due to ...

For patients with STEMI complicated by cardiogenic shock, stark racial/ethnic and sex disparities exist in both the treatments they receive and the outcomes achieved, observational US data show. Prior ...

Despite underrepresentation in clinical trials of acute coronary syndrome treatments, a recent study suggests treatment strategies and outcomes in chronic kidney disease patients with ST-elevation ...